Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT03485547
Brief Title: Study of Venetoclax, a BCL2 Antagonist, for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

First Submitted : March 27, 2018
First Submitted that Met QC Criteria : March 30, 2018
First Posted : April 2, 2018

Last Update Submitted that Met QC Criteria : October 17, 2019
Last Update Posted : October 18, 2019